1. Home
  2. IONQ vs HALO Comparison

IONQ vs HALO Comparison

Compare IONQ & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IONQ
  • HALO
  • Stock Information
  • Founded
  • IONQ 2015
  • HALO 1998
  • Country
  • IONQ United States
  • HALO United States
  • Employees
  • IONQ N/A
  • HALO N/A
  • Industry
  • IONQ Wholesale Distributors
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IONQ Industrials
  • HALO Health Care
  • Exchange
  • IONQ Nasdaq
  • HALO Nasdaq
  • Market Cap
  • IONQ 8.5B
  • HALO 7.4B
  • IPO Year
  • IONQ N/A
  • HALO N/A
  • Fundamental
  • Price
  • IONQ $25.74
  • HALO $58.79
  • Analyst Decision
  • IONQ Strong Buy
  • HALO Buy
  • Analyst Count
  • IONQ 5
  • HALO 9
  • Target Price
  • IONQ $41.80
  • HALO $61.63
  • AVG Volume (30 Days)
  • IONQ 20.7M
  • HALO 1.8M
  • Earning Date
  • IONQ 05-07-2025
  • HALO 05-06-2025
  • Dividend Yield
  • IONQ N/A
  • HALO N/A
  • EPS Growth
  • IONQ N/A
  • HALO 63.33
  • EPS
  • IONQ N/A
  • HALO 3.43
  • Revenue
  • IONQ $43,073,000.00
  • HALO $1,015,324,000.00
  • Revenue This Year
  • IONQ $102.28
  • HALO $20.06
  • Revenue Next Year
  • IONQ $99.79
  • HALO $24.04
  • P/E Ratio
  • IONQ N/A
  • HALO $17.14
  • Revenue Growth
  • IONQ 95.41
  • HALO 22.44
  • 52 Week Low
  • IONQ $6.22
  • HALO $37.73
  • 52 Week High
  • IONQ $54.74
  • HALO $66.00
  • Technical
  • Relative Strength Index (RSI)
  • IONQ 52.40
  • HALO 44.06
  • Support Level
  • IONQ $23.80
  • HALO $57.50
  • Resistance Level
  • IONQ $28.25
  • HALO $62.14
  • Average True Range (ATR)
  • IONQ 2.72
  • HALO 2.90
  • MACD
  • IONQ 0.52
  • HALO -0.40
  • Stochastic Oscillator
  • IONQ 73.41
  • HALO 36.41

About IONQ IonQ Inc.

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: